KONINKLIJKE PHILIPS NV (PHIA.AS) Stock Fundamental Analysis
Europe - AMS:PHIA - NL0000009538 - Common Stock
24.275 EUR
+0.01 (+0.06%)
Overall PHIA gets a fundamental rating of 3 out of 10. We evaluated PHIA against 59 industry peers in the Health Care Equipment & Supplies industry. PHIA has a bad profitability rating. Also its financial health evaluation is rather negative. PHIA has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
PHIA had positive earnings in the past year.
PHIA had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: PHIA reported negative net income in multiple years.
PHIA had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
With a Return On Assets value of 0.61%, PHIA is not doing good in the industry: 62.71% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of 1.56%, PHIA is doing worse than 62.71% of the companies in the same industry.
PHIA's Return On Invested Capital of 4.27% is in line compared to the rest of the industry. PHIA outperforms 42.37% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.61% | ||
| ROE | 1.56% | ||
| ROIC | 4.27% |
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
PHIA has a worse Profit Margin (0.91%) than 62.71% of its industry peers.
With a Operating Margin value of 6.11%, PHIA perfoms like the industry average, outperforming 44.07% of the companies in the same industry.
In the last couple of years the Operating Margin of PHIA has declined.
PHIA has a worse Gross Margin (43.85%) than 71.19% of its industry peers.
PHIA's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.11% | ||
| PM (TTM) | 0.91% | ||
| GM | 43.85% |
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PHIA is destroying value.
The number of shares outstanding for PHIA has been reduced compared to 1 year ago.
PHIA has more shares outstanding than it did 5 years ago.
The debt/assets ratio for PHIA is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 1.94 indicates that PHIA is not a great score, but indicates only limited risk for bankruptcy at the moment.
PHIA has a Altman-Z score (1.94) which is comparable to the rest of the industry.
The Debt to FCF ratio of PHIA is 19.41, which is on the high side as it means it would take PHIA, 19.41 years of fcf income to pay off all of its debts.
PHIA has a Debt to FCF ratio of 19.41. This is comparable to the rest of the industry: PHIA outperforms 40.68% of its industry peers.
A Debt/Equity ratio of 0.69 indicates that PHIA is somewhat dependend on debt financing.
PHIA has a Debt to Equity ratio of 0.69. This is in the lower half of the industry: PHIA underperforms 74.58% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.69 | ||
| Debt/FCF | 19.41 | ||
| Altman-Z | 1.94 |
ROIC/WACC0.65
WACC6.54%
2.3 Liquidity
A Current Ratio of 1.26 indicates that PHIA should not have too much problems paying its short term obligations.
With a Current ratio value of 1.26, PHIA is not doing good in the industry: 61.02% of the companies in the same industry are doing better.
PHIA has a Quick Ratio of 1.26. This is a bad value and indicates that PHIA is not financially healthy enough and could expect problems in meeting its short term obligations.
PHIA has a Quick ratio of 0.81. This is in the lower half of the industry: PHIA underperforms 66.10% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.26 | ||
| Quick Ratio | 0.81 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 11.17% over the past year.
The Earnings Per Share has been decreasing by -7.17% on average over the past years.
Looking at the last year, PHIA shows a decrease in Revenue. The Revenue has decreased by -1.53% in the last year.
Measured over the past years, PHIA shows a small growth in Revenue. The Revenue has been growing by 1.00% on average per year.
EPS 1Y (TTM)11.17%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%21.91%
Revenue 1Y (TTM)-1.53%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-2.12%
3.2 Future
PHIA is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.26% yearly.
The Revenue is expected to grow by 3.26% on average over the next years.
EPS Next Y0.42%
EPS Next 2Y5.48%
EPS Next 3Y7.81%
EPS Next 5Y12.26%
Revenue Next Year-1.83%
Revenue Next 2Y0.64%
Revenue Next 3Y1.91%
Revenue Next 5Y3.26%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 16.86 indicates a correct valuation of PHIA.
Compared to the rest of the industry, the Price/Earnings ratio of PHIA indicates a rather cheap valuation: PHIA is cheaper than 88.14% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.42, PHIA is valued a bit cheaper.
Based on the Price/Forward Earnings ratio of 15.75, the valuation of PHIA can be described as correct.
72.88% of the companies in the same industry are more expensive than PHIA, based on the Price/Forward Earnings ratio.
PHIA's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.94.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.86 | ||
| Fwd PE | 15.75 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, PHIA is valued a bit cheaper than 71.19% of the companies in the same industry.
PHIA's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 53.86 | ||
| EV/EBITDA | 12.56 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PHIA does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)40.62
PEG (5Y)N/A
EPS Next 2Y5.48%
EPS Next 3Y7.81%
5. Dividend
5.1 Amount
No dividends for PHIA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
AMS:PHIA (10/20/2025, 12:41:07 PM)
24.275
+0.01 (+0.06%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners47.54%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap23.38B
Analysts74.81
Price Target27.28 (12.38%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)-70.49%
DP0.62%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)26.64%
Min EPS beat(2)22.24%
Max EPS beat(2)31.04%
EPS beat(4)2
Avg EPS beat(4)6.19%
Min EPS beat(4)-16.56%
Max EPS beat(4)31.04%
EPS beat(8)3
Avg EPS beat(8)-1.09%
EPS beat(12)5
Avg EPS beat(12)15.29%
EPS beat(16)5
Avg EPS beat(16)3.51%
Revenue beat(2)0
Avg Revenue beat(2)-1.96%
Min Revenue beat(2)-1.97%
Max Revenue beat(2)-1.96%
Revenue beat(4)0
Avg Revenue beat(4)-3.05%
Min Revenue beat(4)-5.22%
Max Revenue beat(4)-1.96%
Revenue beat(8)0
Avg Revenue beat(8)-3.22%
Revenue beat(12)2
Avg Revenue beat(12)-1.61%
Revenue beat(16)2
Avg Revenue beat(16)-1.84%
PT rev (1m)-0.47%
PT rev (3m)4.09%
EPS NQ rev (1m)-0.38%
EPS NQ rev (3m)-3.82%
EPS NY rev (1m)-0.76%
EPS NY rev (3m)-8.66%
Revenue NQ rev (1m)-0.41%
Revenue NQ rev (3m)-3.44%
Revenue NY rev (1m)-0.16%
Revenue NY rev (3m)-2.94%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.86 | ||
| Fwd PE | 15.75 | ||
| P/S | 1.31 | ||
| P/FCF | 53.86 | ||
| P/OCF | 21.27 | ||
| P/B | 2.25 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.56 |
EPS(TTM)1.44
EY5.93%
EPS(NY)1.54
Fwd EY6.35%
FCF(TTM)0.45
FCFY1.86%
OCF(TTM)1.14
OCFY4.7%
SpS18.54
BVpS10.78
TBVpS-1.76
PEG (NY)40.62
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.61% | ||
| ROE | 1.56% | ||
| ROCE | 5.69% | ||
| ROIC | 4.27% | ||
| ROICexc | 4.72% | ||
| ROICexgc | 15.5% | ||
| OM | 6.11% | ||
| PM (TTM) | 0.91% | ||
| GM | 43.85% | ||
| FCFM | 2.43% |
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y10.6%
ROICexcg growth 5Y-2.51%
ROICexc growth 3Y4.73%
ROICexc growth 5Y-6.98%
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
F-Score8
Asset Turnover0.68
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.69 | ||
| Debt/FCF | 19.41 | ||
| Debt/EBITDA | 3.01 | ||
| Cap/Depr | 51.35% | ||
| Cap/Sales | 3.72% | ||
| Interest Coverage | 4 | ||
| Cash Conversion | 46.06% | ||
| Profit Quality | 267.9% | ||
| Current Ratio | 1.26 | ||
| Quick Ratio | 0.81 | ||
| Altman-Z | 1.94 |
F-Score8
WACC6.54%
ROIC/WACC0.65
Cap/Depr(3y)50.01%
Cap/Depr(5y)53.78%
Cap/Sales(3y)3.94%
Cap/Sales(5y)4.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)11.17%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%21.91%
EPS Next Y0.42%
EPS Next 2Y5.48%
EPS Next 3Y7.81%
EPS Next 5Y12.26%
Revenue 1Y (TTM)-1.53%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-2.12%
Revenue Next Year-1.83%
Revenue Next 2Y0.64%
Revenue Next 3Y1.91%
Revenue Next 5Y3.26%
EBIT growth 1Y476.21%
EBIT growth 3Y0.03%
EBIT growth 5Y-7.17%
EBIT Next Year48.14%
EBIT Next 3Y21.01%
EBIT Next 5YN/A
FCF growth 1Y3516.67%
FCF growth 3Y-40.93%
FCF growth 5Y-1.73%
OCF growth 1Y43.47%
OCF growth 3Y-32.38%
OCF growth 5Y-4.03%